These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20385221)

  • 21. Construction and in vitro/in vivo evaluation of 17-allylamino-17-demethoxygeldanamycin (17AAG)-loaded PEGylated nanostructured lipid carriers.
    Wang Z; Wang J; Yang S; Hou S
    Drug Dev Ind Pharm; 2016 Jan; 42(1):91-98. PubMed ID: 25853294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification.
    Yuan H; Wang LL; Du YZ; You J; Hu FQ; Zeng S
    Colloids Surf B Biointerfaces; 2007 Nov; 60(2):174-9. PubMed ID: 17656075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats.
    Zhang S; Wang J; Pan J
    Drug Deliv; 2016 Nov; 23(9):3696-3703. PubMed ID: 27749105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting.
    Tsai MJ; Wu PC; Huang YB; Chang JS; Lin CL; Tsai YH; Fang JY
    Int J Pharm; 2012 Feb; 423(2):461-70. PubMed ID: 22193056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
    Chen Y; Pan L; Jiang M; Li D; Jin L
    Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid.
    Silva EL; Carneiro G; Caetano PA; Goulart G; Ferreira Costa D; de Souza-Fagundes EM; Gomes DA; Ferreira LA
    Expert Rev Anticancer Ther; 2015 Feb; 15(2):247-56. PubMed ID: 25611812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion.
    Huang ZR; Hua SC; Yang YL; Fang JY
    Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization.
    Shete H; Patravale V
    Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug.
    Chinsriwongkul A; Chareanputtakhun P; Ngawhirunpat T; Rojanarata T; Sila-on W; Ruktanonchai U; Opanasopit P
    AAPS PharmSciTech; 2012 Mar; 13(1):150-8. PubMed ID: 22167418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
    Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
    Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriers.
    Luan J; Zhang D; Hao L; Qi L; Liu X; Guo H; Li C; Guo Y; Li T; Zhang Q; Zhai G
    Colloids Surf B Biointerfaces; 2014 Feb; 114():255-60. PubMed ID: 24211416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications.
    Ara├║jo J; Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
    Int J Pharm; 2010 Jun; 393(1-2):167-75. PubMed ID: 20362042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers.
    Rizwanullah M; Amin S; Ahmad J
    J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers.
    Wang F; Chen J; Dai W; He Z; Zhai D; Chen W
    Acta Pharm; 2017 Sep; 67(3):357-371. PubMed ID: 28858837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells.
    Zhou J; Sun M; Jin S; Fan L; Zhu W; Sui X; Cao L; Yang C; Han C
    Drug Deliv; 2019 Dec; 26(1):281-289. PubMed ID: 30880491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orcinol Glucoside Loaded Polymer - Lipid Hybrid Nanostructured Lipid Carriers: Potential Cytotoxic Agents against Gastric, Colon and Hepatoma Carcinoma Cell Lines.
    Nahak P; Gajbhiye RL; Karmakar G; Guha P; Roy B; Besra SE; Bikov AG; Akentiev AV; Noskov BA; Nag K; Jaisankar P; Panda AK
    Pharm Res; 2018 Aug; 35(10):198. PubMed ID: 30151753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
    Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
    Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies.
    Jia L; Zhang D; Li Z; Duan C; Wang Y; Feng F; Wang F; Liu Y; Zhang Q
    Colloids Surf B Biointerfaces; 2010 Oct; 80(2):213-8. PubMed ID: 20621458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacoscintigraphic evaluation of potential of lipid nanocarriers for nose-to-brain delivery of antidepressant drug.
    Alam MI; Baboota S; Ahuja A; Ali M; Ali J; Sahni JK; Bhatnagar A
    Int J Pharm; 2014 Aug; 470(1-2):99-106. PubMed ID: 24810241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part II. In vivo biodistribution, pharmacodynamic and hematological toxicity studies.
    Negi LM; Talegaonkar S; Jaggi M; Verma AK; Verma R; Dobhal S; Kumar V
    Colloids Surf B Biointerfaces; 2014 Nov; 123():610-5. PubMed ID: 25454755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.